Blood coagulation and fibrinolytic factors in 105 patients with hemorrhagic syndrome caused by accidental contact with Lonomia obliqua caterpillar in Santa Catarina, Southern Brazil

Thrombosis and Haemostasis

Volumn 89, Issue 2, 2003, Pages 355-364

  Zannin, Marlene ^a   Lourenco, Dayse M ^b   Motta, Guacyara ^b   Dalla Costa, Luis R ^c   Grando, Margaret ^d   Gamborgi, Geni P ^c   Noguti, Maria A ^b   Chudzinski Tavassi, Ana M ^e  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c Chapeco Blood Center Santa Catarina   (Brazil)

^d CIT/SC   (Brazil)

^e INSTITUTO BUTANTAN   (Brazil)

Author keywords

Coagulation; DIC; Envenomation; Fibrinolysis; Lonomia obliqua

Indexed keywords

ALPHA 2 ANTIPLASMIN; ANTITHROMBIN; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; D DIMER; FIBRIN; FIBRINOGEN; INSECT VENOM; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREKALLIKREIN; PROTEIN C; PROTEIN S; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; BRAZIL; CATERPILLAR; CONTROLLED STUDY; ENVENOMATION; FIBRIN FORMATION; FIBRINOGEN BLOOD LEVEL; FIBRINOLYSIS; HUMAN; INSECT; LABORATORY TEST; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; THROMBOCYTE COUNT;

EID: 0037324202     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613453     Document Type: Article

References (33)

1. Arocha-Piñango CL, Layrisse M. Fibrinolysis produed by contact with a caterpillar. Lancet 1969; 7597: 810-2.
2. Arocha-Piñango CL, Bosch NB, Torres A, Goldstein C, Nouel A, Argiello A, Carvajal Z, Guerrero B, Ojeda A, Rodriguez A, Rodriguez S. Six new caes of a caterpillar-induced bleeding syndrome. Thromb Haemost 1992; 67: 402-7.
3. Kelen EMA, Picarelli ZP, Duarte AC. Hemorrhagic syndrome induced by contact with caterpillars of the genus Lonomia (saturniidae, hemileucinae). J Toxinol Toxin Rev 1995; 14: 283-308.
4. Duarte ACL, Crusius PS, Pires CAL, Schilling MA, Fan HW. Intracerebral haemorrhage after contact with Lonomia caterpillars. Lancet 1996; 348: 1033.
5. Burdmann EA, Antunes I, Saldanha LB, Abdulkader RCMR. Severe acute renal failure induced by the venon of Lonomia caterpillars. Clin Nephrol 1996; 46: 337-9.
6. ++ activated serine protease (Lopap) could be responsible for the haemorrhagic syndrome caused by the caterpillar Lonomia obliqua. Lancet 1999; 353: 1942.
7. Reis CV, Portaro FCV, Andrade SA, Fritzen M, Sampaio CAM, Camargo ACM, Chudzinski-Tavassi AM. A prothrombin activator serine protease from the Lonomia obliqua caterpillars venon (Lopap): Biochemical characterization. Thromb Res 2001; 102: 427-36.
8. Donato JL, Moreno RA, Hyslop S, Duarte A, Antunes E, Le Bonniec BF, Rendu F, Nucci G. Lonomia obliqua caterpillar spicules trigger human blood coagulation via activation of factoro X and prothrombin. Thromb Haemost 1998; 79: 539-42.
9. Guerrero B, Arocha-Piñango CL. Activation of human prothrombin by the venom of Lonomia achelous (Cramer) caterpillars. Thromb Res 1992; 66: 169-77.
10. Amarant T, Burkhart W, Le Vine H, Arocha-Piñango CL, Parikh I. Isolation and complete amino acid sequence of two fibrinolytic proteinases from the toxic saturnid caterpillar Lonomia achelous. Biochim Biophys Acta 1991; 1079: 214-21.
11. Spero AJ, Lewis JH, Hasiba U. Desseminated intravascular coagulation findings in 346 patients. Thromb Haemost 1980; 43: 28-33.
12. Okajima K, Sakamoto Y, Uchiba M. Heterogeneity in the incidence and clinical manifestations of disseminated intravascular coagulation: A study of 204 cases. Am J Hematol 2000; 65: 215-22.
13. Wada H, Yoshihiro W, Nakasaki T, Shimura M, Hiyoyama K, Nagaya S, Mori Y, Shiku H. Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Thromb Haemost 1995; 74: 848-52.
14. Wada H, Sakuragawa N, Mori Y, Takagi M, Nakasaki T, Shimura M, Hiyoyama K, Nisikawa M, Gabazza EC, Deguchi K, Kazama M, Shiku H. Haemostatic molecular markers before the onset of disseminated intravascular coagulation. Am J Hematol 1999; 60: 273-8.
15. Motta G, Rojkjaer R, Hasan AA, Cines DB, Schmaier AH. High molecular weight kininogen regulates prekallikrein assembly and activation on endothelial cells: A novel mechanism for contact activation. Blood 1998; 91: 516-28.
16. Motta G, Shariat-Madar Z, Mahdi F, Sampaio CAM, Schmaier AH. Assembly of high molecular weight kininogen and activation of prekallikerin on cell matrix. Thromb Haemost 2001; 96: 840-7.
17. Guerrero BA, Arocha-Piñango Cl, San Juan Ag. Lonomia achelous caterpilar venom (LACV) selectively inactivates blood clotting factor XIII. Thromb Res 1997; 87: 83-93.
18. Guerrero BA, Arocha-Piñango Cl, San Juan Ag. Degradation of human factor XIII by Lonomin V, a purified fraction of Lonomia achelous caterpillar venom. Thromb Res 1997; 87: 171-81.
19. Zuch A, Kloczko J, Bielawiec M, Mysliwiec M, Grabowski R, Buluk K. Fibrin stabilizing factor (factor XIII) consumption as an indicator of disseminated intravascular coagulation (DIC). Folia Haematol 1977; 104: 874-8.
20. Sugimura D, Fukue H, Arai M, Matsumoto K, Fukutake K. Changes of factor XIII a and b subunit in patients with disseminated intravascular coagulation syndrome. Rinsho Byori 1996; 44: 355-61.
21. Asakura H, Shiratori Y, Jokaji H, Saito M, Uotani C, Kumabashiri I, Morishita E, Yamazaki M, Matsuda T. Changes in plasma levels of prothrombin fragment F1 + 2 in cases of disseminated intravascular coagulation. Acta Haematol 1993; 89: 22-5.
22. Asakura H, Ontachi Y, Mizutani T, Kato M, Saito M, Morishita E, Yamazaki M, Suga Y, Takami A, Miyamoto K, Nakao S. Elevated levels of free tissue factor pathway inhibitor antigen in cases of disseminated intravascular coagulation caused by various underlying diseases. Blood Coagul Fibrinolysis 2001; 12: 1-8.
23. Braat EA, Levi M, Bos R, Haverkate F, Lassen MR, De Maat MP, Rijken DC. Inactivation of single-chain urokinase-type plasminogen activator by thrombin in human subjects. J Lab Clin Med 1999; 134: 161-7.
24. Takahashi H, Wada K, Niwano H, Shibata A. Comparison of prothrombin fragment 1 + 2 with thrombin-antithrombin III complex in plasma of patients with disseminated intravascular coagulation. Blood Coagul Fibrinolysis 1992; 3: 813-8.
25. Sorensen JV, Rahr HB, Jensen HP, Borris LC, Lassen MR, Ejstrud P. Markers of coagulation and fibrinolysis after factures of the lower extremities. Thromb Res 1992; 65: 479-86.
26. Baudo F, Caimi TM, De Cataldo F, Ravizza A, Arlati S, Casella G, Carugo D, Palareti G, Legnani C, Ridolfi L, Rossi D, D'Angelo A, Crippa L, Guidici D, Gallioli G, Wolfer A, Calori G. Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: A controlled double-blind, randomized, multicenter study. Intensive Care Med 1998; 24: 336-42.
27. Asakura H, Ontachi Y, Mizutani T, Kato M, Saito M, Morishita E, Yamazaki M, Aoshima K, Takami A, Yoshida T, Suga Y, Miyamoto K-I, Nakao S. Decreased plasma activity of antithrombin or protein C is not due to consumption coagulopathy in septic patients with disseminated intravascular coagulation. Eur J Haematol 2001; 67: 170-5.
28. Thorsen LI, Brosstad F, Gogstad G, Sletten K, Solum NO. Competitions between fibrinogen with its degradation products for interactions with the platelet-fibrinogen receptor. Thromb Res 1986; 44: 611-23.
29. Gaffney PJ. Fibrin degradation products: A review of structures found in vitro and in vivo. Ann N Y Acad Sci 2001; 936: 594-610.
30. Raaphrost J, Groeneveld ABJ, Bossink AW, Hack CE. Early inhibition of activated fibrinolysis predicts microbial infection, shock and mortality in febrile medical patients. Thromb Haemost 2001; 86: 543-9.
31. Reis CV, Farsky SHP, Fernandes BL, Santoro ML, Oliva MLV, Mariano M, Chudzinski-Tavassi AM. In vivo characterization of lopap, a prothrombin activator serine protease from the Lonomia obliqua caterpillar venom. Thromb Res 2001; 102: 437-43.
32. Chudzinski-Tavassi AM, Schattner M, Fritzen M, Pozner RG, Reis CV, Lourenço D, Lazzari MA. Effects of lopap on human endothelial cells and platelets. Haemostasis 2001; 3: 257-65.
33. Hoffmeister HM, Szabo S, Kastner C, Beyer ME, Helber U, Kazmaier S, Wendel HP, Heller W, Seipel L. Thrombolytic therapy in acute myocardial infarction: Comparison of procoagulant effects of strepkinase and alteplase regimens with focus on the kallikrein system and plasmin. Circulation 1998; 98: 2527-53.